Quantitative Sensory Testing of the Lower Lip After Inferior Alveolar Nerve Block, and Evaluation of the Role of the Contra-lateral Inferior Alveolar Nerve
NCT01530074 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2021-08-27
Summary
The purpose of this study is to determine the contribution of the innervation of the contra-lateral mandibular nerve for the innervation of the lower lip area.
The investigators hypothesis is that the sensation of the lower lip is contributed by both mandibular nerves (from both sides of the jaw).
Conditions
- Healthy
Interventions
- PROCEDURE
-
Temporary blocking of mandibular nerve
IM. Lidocaine 2% 7.2ML
Sponsors & Collaborators
-
K Blal
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2013-08-31
- Completion
- 2013-12-31
More Related Trials
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)
NCT00964990 ·Status: TERMINATED ·Phase: PHASE2
-
Oral Ketamine Administration in Patients With Peripheral Neuropathic Pain
NCT00961194 ·Status: COMPLETED ·Phase: PHASE2
-
Neuroma Injections to Treat Restless Legs Syndrome - RCT
NCT00656110 ·Status: UNKNOWN ·Phase: NA
-
Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain
NCT06053242 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
IV Lidocaine Infusion for Neuropathic Pain
NCT05731739 ·Status: WITHDRAWN
-
Impact of Peripheral Afferent Input on Central Neuropathic Pain
NCT05646810 ·Status: UNKNOWN ·Phase: NA
-
Impact of Teflon Technique on Recurrence After Microvascular Decompression for Trigeminal Neuralgia
NCT07046247 ·Status: COMPLETED
-
A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021
NCT01121380 ·Status: TERMINATED ·Phase: PHASE1
-
Randomized Study of L-Baclofen in Patients With Refractory Trigeminal Neuralgia
NCT00004431 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Botox to Treat Neuropathic Pain
NCT00527202 ·Status: COMPLETED ·Phase: PHASE4
-
Lidocaine 5% Medicated Plaster in Chronic Neuropathic Postoperative Pain
NCT01155986 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.
NCT07276542 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Ketamine and Neuropathic Pain
NCT02467517 ·Status: UNKNOWN ·Phase: PHASE2
-
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back Pain
NCT00973024 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of Upper Cluneal Nerve Entrapment Syndrome for Reduction of Low Back Pain
NCT06059612 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain
NCT03341832 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term Outcome After Serial Lidocaine Infusion in Peripheral Neuropathic Pain
NCT02217267 ·Status: COMPLETED ·Phase: PHASE3
-
Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA)
NCT04673981 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients
NCT06595004 ·Status: COMPLETED ·Phase: PHASE3
-
Blood Levels of Ketamine in Patients Using Topical Application of 10% Ketamine Gel for Neuropathic Pain
NCT01385904 ·Status: UNKNOWN
-
Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain
NCT00414349 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain
NCT02597257 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a Neuropathic Component
NCT01838044 ·Status: TERMINATED ·Phase: PHASE4
-
Study to Evaluate the Efficacy of Lithium Carbonate in Spinal Cord Injury Patients With Neuropathic Pain
NCT01855594 ·Status: COMPLETED ·Phase: PHASE2
-
Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy
NCT00050271 ·Status: COMPLETED ·Phase: NA